{"id":"placebo-bid","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is a non-therapeutic agent administered in blinded studies to serve as a control comparator. Any observed effects are attributable to the placebo effect—psychological and contextual factors rather than direct drug action. BID (twice daily) refers only to the dosing schedule.","oneSentence":"Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:39.807Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05754957","phase":"PHASE3","title":"A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-07","conditions":"Acute Coronary Syndrome","enrollment":14194},{"nctId":"NCT05791604","phase":"NA","title":"The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-04-01","conditions":"Prader-Willi Syndrome","enrollment":60},{"nctId":"NCT04669158","phase":"PHASE1, PHASE2","title":"Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-07-30","conditions":"Non Alcoholic Steatohepatitis, Fibrosis","enrollment":53},{"nctId":"NCT06044935","phase":"NA","title":"Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-01-08","conditions":"Overweight, Obesity","enrollment":100},{"nctId":"NCT02443077","phase":"PHASE3","title":"Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-10-12","conditions":"Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type","enrollment":94},{"nctId":"NCT07495852","phase":"PHASE3","title":"Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2026-02-17","conditions":"Glaucoma","enrollment":510},{"nctId":"NCT05009862","phase":"PHASE4","title":"The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-04-19","conditions":"Peripheral Arterial Disease","enrollment":60},{"nctId":"NCT07210723","phase":"PHASE2, PHASE3","title":"A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Kardigan, Inc.","startDate":"2026-02-13","conditions":"Symptomatic Genetic Dilated Cardiomyopathy","enrollment":332},{"nctId":"NCT06954987","phase":"PHASE2","title":"Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-17","conditions":"Acute Myeloid Leukemia","enrollment":244},{"nctId":"NCT05840159","phase":"PHASE4","title":"A Study of Doxycycline to Treat Chlamydial Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-01-19","conditions":"Chlamydial Infection","enrollment":526},{"nctId":"NCT03844061","phase":"PHASE2","title":"Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-29","conditions":"Systemic Sclerosis","enrollment":30},{"nctId":"NCT06948097","phase":"PHASE1","title":"Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies","status":"NOT_YET_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2026-04-01","conditions":"Lung Transplantation","enrollment":30},{"nctId":"NCT05564390","phase":"PHASE2","title":"MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-06-18","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy","enrollment":2000},{"nctId":"NCT04628026","phase":"PHASE3","title":"Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2022-09-13","conditions":"Acute Myeloid Leukemia","enrollment":650},{"nctId":"NCT02152982","phase":"PHASE2, PHASE3","title":"Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-15","conditions":"Glioblastoma, Gliosarcoma","enrollment":447},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT04858334","phase":"PHASE2","title":"APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-06-22","conditions":"Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma","enrollment":152},{"nctId":"NCT07332091","phase":"PHASE2","title":"Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2026-01-22","conditions":"Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis","enrollment":84},{"nctId":"NCT07494253","phase":"NA","title":"Effects of Reducose on Postprandial Glycemic Levels in Obese Children and Adolescents","status":"ENROLLING_BY_INVITATION","sponsor":"University of Bari Aldo Moro","startDate":"2025-06-01","conditions":"Obesity","enrollment":80},{"nctId":"NCT06964776","phase":"PHASE1","title":"A Study of LY4268989 (MORF-057) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2025-05-01","conditions":"Healthy","enrollment":144},{"nctId":"NCT01386385","phase":"PHASE1, PHASE2","title":"Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-06-20","conditions":"Lung Adenocarcinoma, Lung Adenocarcinoma, Mixed Subtype, Lung Large Cell Carcinoma","enrollment":53},{"nctId":"NCT06840496","phase":"PHASE3","title":"To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome","status":"RECRUITING","sponsor":"Biomed Industries, Inc.","startDate":"2026-09-30","conditions":"Rett Syndrome","enrollment":210},{"nctId":"NCT07496034","phase":"PHASE3","title":"Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial","status":"RECRUITING","sponsor":"Tsai, Chueh-Yi, MD","startDate":"2025-07-01","conditions":"Episodic Migraine","enrollment":40},{"nctId":"NCT06063486","phase":"PHASE2","title":"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2024-03-01","conditions":"Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome","enrollment":30},{"nctId":"NCT06022822","phase":"PHASE2","title":"Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-09-12","conditions":"Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT03947827","phase":"PHASE3","title":"Minocycline as Adjunctive Treatment for Treatment Resistant Depression","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2020-02-01","conditions":"Treatment Resistant Depression","enrollment":76},{"nctId":"NCT05965726","phase":"PHASE2","title":"RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2023-07-26","conditions":"Long COVID-19, Long COVID","enrollment":964},{"nctId":"NCT02122185","phase":"PHASE2","title":"Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02-25","conditions":"Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion","enrollment":111},{"nctId":"NCT07496177","phase":"PHASE2","title":"A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences","startDate":"2026-05-01","conditions":"T2DM, CKD","enrollment":75},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT06968845","phase":"PHASE2","title":"A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Rein Therapeutics","startDate":"2026-02-02","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":120},{"nctId":"NCT04297683","phase":"PHASE2, PHASE3","title":"HEALEY ALS Platform Trial - Master Protocol","status":"RECRUITING","sponsor":"Merit E. Cudkowicz, MD","startDate":"2020-06-14","conditions":"Amyotrophic Lateral Sclerosis","enrollment":1500},{"nctId":"NCT04407754","phase":"NA","title":"Myo-Inositol for Infertility in PCOS","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2022-02-07","conditions":"Polycystic Ovary Syndrome","enrollment":168},{"nctId":"NCT05942911","phase":"PHASE2","title":"Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Incannex Healthcare Ltd","startDate":"2023-11-22","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT02194738","phase":"NA","title":"Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-09-26","conditions":"Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8","enrollment":8300},{"nctId":"NCT06679140","phase":"PHASE3","title":"A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease","status":"RECRUITING","sponsor":"Pfizer","startDate":"2024-12-08","conditions":"COVID-19 SARS-CoV-2 Infection","enrollment":2330},{"nctId":"NCT03372811","phase":"PHASE2","title":"Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)","status":"COMPLETED","sponsor":"Psoriasis Research Institute of Guangzhou","startDate":"2015-06-11","conditions":"Psoriasis Vulgaris, Topical Administration","enrollment":88},{"nctId":"NCT06969859","phase":"NA","title":"Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-10-15","conditions":"Mid-portion Achilles Tendinopathy","enrollment":200},{"nctId":"NCT06439875","phase":"NA","title":"Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation.","status":"COMPLETED","sponsor":"Istituti Clinici Scientifici Maugeri SpA","startDate":"2024-07-16","conditions":"Chronic Obstructive Pulmonary Disease, Respiratory Failure","enrollment":101},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":"Periodontal Disease (PD), Cardio Vascular Disease, Oral-Systemic Link","enrollment":30},{"nctId":"NCT04026997","phase":"PHASE2","title":"A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis","status":"TERMINATED","sponsor":"CinDome Pharma, Inc.","startDate":"2019-09-11","conditions":"Gastroparesis","enrollment":72},{"nctId":"NCT07264192","phase":"PHASE1","title":"A Study of HS-10518 in Healthy Adult Premenopausal Females in China","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2025-03-11","conditions":"Infertility, Female","enrollment":60},{"nctId":"NCT06629779","phase":"PHASE3","title":"A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.","status":"RECRUITING","sponsor":"Pfizer","startDate":"2024-10-22","conditions":"Metastatic Castration-Resistant Prostate Cancer","enrollment":900},{"nctId":"NCT05568498","phase":"PHASE2","title":"Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-01-20","conditions":"Parkinson Disease, Depression, PARKINSON DISEASE (Disorder)","enrollment":60},{"nctId":"NCT07490873","phase":"NA","title":"Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients","status":"RECRUITING","sponsor":"University of Baghdad","startDate":"2026-01-05","conditions":"Effectiveness of Chlorohexidine, Effectiveness of Essential Oil, Effectiveness of Cetylpyridinium Chloride","enrollment":24},{"nctId":"NCT03747458","phase":"PHASE3","title":"OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps","status":"RECRUITING","sponsor":"Optinose US Inc.","startDate":"2018-12-31","conditions":"Bilateral Nasal Polyposis","enrollment":72},{"nctId":"NCT07491458","phase":"PHASE2","title":"A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Rivus Pharmaceuticals, Inc.","startDate":"2026-02-13","conditions":"MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":180},{"nctId":"NCT06958835","phase":"NA","title":"Linezolid Plus Standard of Care","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-10-06","conditions":"Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)","enrollment":606},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":"Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases","enrollment":2410},{"nctId":"NCT02763033","phase":"PHASE2","title":"Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2017-04-26","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":107},{"nctId":"NCT03617679","phase":"PHASE2","title":"Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-03-06","conditions":"Metastatic Endometrial Cancer","enrollment":79},{"nctId":"NCT07477288","phase":"PHASE2","title":"Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging","status":"COMPLETED","sponsor":"Hasanuddin University","startDate":"2025-03-12","conditions":"Skin Aging","enrollment":44},{"nctId":"NCT07123155","phase":"PHASE2","title":"Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)","status":"RECRUITING","sponsor":"Shionogi","startDate":"2025-10-30","conditions":"Pompe Disease","enrollment":45},{"nctId":"NCT07355062","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis","status":"RECRUITING","sponsor":"Renibus Therapeutics, Inc.","startDate":"2026-01-13","conditions":"CKD, Metabolic Acidosis","enrollment":150},{"nctId":"NCT06423235","phase":"PHASE4","title":"Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules","status":"RECRUITING","sponsor":"Xintian Pharmaceutical","startDate":"2024-07-30","conditions":"Thyroid Nodule","enrollment":234},{"nctId":"NCT07325266","phase":"PHASE2","title":"Human Laboratory Study of Apremilast for Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2026-04-01","conditions":"Alcohol Use Disorder, Alcohol Misuse","enrollment":100},{"nctId":"NCT07384052","phase":"PHASE1","title":"Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2026-02-20","conditions":"Spinal Cord Injury","enrollment":12},{"nctId":"NCT04472598","phase":"PHASE3","title":"Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-09-29","conditions":"Myelofibrosis (MF)","enrollment":252},{"nctId":"NCT04597359","phase":"PHASE2","title":"To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-10-05","conditions":"Prostate Carcinoma","enrollment":360},{"nctId":"NCT03969953","phase":"PHASE3","title":"Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease","status":"COMPLETED","sponsor":"The George Institute","startDate":"2021-01-18","conditions":"Chronic Kidney Diseases, Dialysis-dependent Kidney Failure, Cardiovascular Disease","enrollment":1753},{"nctId":"NCT07488949","phase":"NA","title":"Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF)","status":"RECRUITING","sponsor":"Fang Wang","startDate":"2024-04-09","conditions":"Chronic Endometritis","enrollment":1000},{"nctId":"NCT06850805","phase":"PHASE3","title":"Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Optinose US Inc.","startDate":"2025-07-28","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":84},{"nctId":"NCT07393360","phase":"NA","title":"Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2025-12-11","conditions":"Obesity & Overweight","enrollment":144},{"nctId":"NCT07226895","phase":"PHASE1, PHASE2","title":"A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis","status":"RECRUITING","sponsor":"Monument Therapeutics Limited","startDate":"2026-03","conditions":"Clinical High Risk for Psychosis (CHR)","enrollment":150},{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT04781543","phase":"PHASE2","title":"A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis","status":"TERMINATED","sponsor":"Amgen","startDate":"2021-11-05","conditions":"Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic","enrollment":301},{"nctId":"NCT05488340","phase":"PHASE2","title":"A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)","status":"RECRUITING","sponsor":"Locus Biosciences","startDate":"2022-07-13","conditions":"Urinary Tract Infections","enrollment":318},{"nctId":"NCT06374693","phase":"NA","title":"Investigating the Tolerability and Feasibility of tVNS Following aSAH","status":"RECRUITING","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2024-04-17","conditions":"Subarachnoid Haemorrhage From Cerebral Aneurism Rupture","enrollment":30},{"nctId":"NCT07355218","phase":"PHASE3","title":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)","status":"NOT_YET_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2026-03-27","conditions":"Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus","enrollment":202},{"nctId":"NCT06512389","phase":"PHASE2","title":"Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-08-16","conditions":"Alcohol Use Disorder","enrollment":36},{"nctId":"NCT07484412","phase":"NA","title":"Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2025-08-01","conditions":"Lower Abdominal Pain, Diarrhea, Irritable Bowel Syndrome","enrollment":88},{"nctId":"NCT05702398","phase":"EARLY_PHASE1","title":"Pilot Trial of Supplemental Vitamin A and Nicotinamide","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2023-04-01","conditions":"Skin Cancer, Kidney Transplant Recipients","enrollment":30},{"nctId":"NCT07169318","phase":"PHASE1","title":"First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-16","conditions":"Influenza","enrollment":78},{"nctId":"NCT07332481","phase":"PHASE3","title":"A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease","status":"NOT_YET_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2026-03-27","conditions":"Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)","enrollment":202},{"nctId":"NCT07339631","phase":"PHASE1","title":"Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2026-03-01","conditions":"Low Back Pain, Paraspinal Muscle, CLBP - Chronic Low Back Pain","enrollment":40},{"nctId":"NCT07483632","phase":"PHASE3","title":"A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)","status":"NOT_YET_RECRUITING","sponsor":"Biogen","startDate":"2026-11-16","conditions":"Relapsing Forms of Multiple Sclerosis","enrollment":185},{"nctId":"NCT06828861","phase":"PHASE3","title":"ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial","status":"SUSPENDED","sponsor":"Aardvark Therapeutics, Inc.","startDate":"2024-12-20","conditions":"Hyperphagia, Prader-Willi Syndrome","enrollment":90},{"nctId":"NCT07482644","phase":"NA","title":"Efficacy and Safety of an Essential Oil-Based Product System for Immune Support","status":"NOT_YET_RECRUITING","sponsor":"dōTERRA International","startDate":"2026-05-04","conditions":"Immune System Function, Inflammation","enrollment":40},{"nctId":"NCT06282588","phase":"PHASE2, PHASE3","title":"Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2023-12-13","conditions":"Prostate Cancer","enrollment":493},{"nctId":"NCT07181382","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"SUSPENDED","sponsor":"GB002, Inc.","startDate":"2026-02","conditions":"Pulmonary Hypertension Associated With Interstitial Lung Disease","enrollment":480},{"nctId":"NCT02257736","phase":"PHASE3","title":"An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2014-11-26","conditions":"Prostatic Neoplasms","enrollment":982},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT06732388","phase":"PHASE2","title":"Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-16","conditions":"Barrett Esophagus, Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8","enrollment":64},{"nctId":"NCT07483398","phase":"PHASE4","title":"RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-13","conditions":"Parkinson's Disease With Nociceptive Pain","enrollment":166},{"nctId":"NCT06731764","phase":"PHASE2, PHASE3","title":"Novel Approaches to the Treatment of Hypothyroidism","status":"RECRUITING","sponsor":"UConn Health","startDate":"2024-12-10","conditions":"Hypothyroidism","enrollment":90},{"nctId":"NCT07257029","phase":"PHASE2","title":"Topical Ketotifen 0.25% for Secondary Vestibulodynia","status":"RECRUITING","sponsor":"Center for Vulvovaginal Disorders","startDate":"2026-01-02","conditions":"Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, Vulvodynia","enrollment":54},{"nctId":"NCT07481422","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2026-03-15","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":70},{"nctId":"NCT07480668","phase":"NA","title":"Aromatherapy for Mental Health Promotion in IVF Patients","status":"RECRUITING","sponsor":"Federal University of Minas Gerais","startDate":"2026-03","conditions":"Anxiety, Stress, Depression Disorder","enrollment":120},{"nctId":"NCT05934526","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)","status":"COMPLETED","sponsor":"GB002, Inc.","startDate":"2023-12-28","conditions":"Pulmonary Arterial Hypertension","enrollment":390},{"nctId":"NCT06329401","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Avalyn Pharma Inc.","startDate":"2024-04-03","conditions":"Progressive Pulmonary Fibrosis","enrollment":375},{"nctId":"NCT06381791","phase":"PHASE1, PHASE2","title":"CBD for Pain Following Orthopedic Shoulder Surgery","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-05-24","conditions":"Shoulder Osteoarthritis, Rotator Cuff Injuries","enrollment":80},{"nctId":"NCT05538208","phase":"PHASE2","title":"The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-06-07","conditions":"Lupus Nephritis","enrollment":105},{"nctId":"NCT05983588","phase":"PHASE2","title":"PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Technical University of Munich","startDate":"2023-12-12","conditions":"Corticobasal Syndrome (CBS)","enrollment":32},{"nctId":"NCT06148038","phase":"PHASE1","title":"CBD for Breast Cancer Primary Tumors","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-06-15","conditions":"Breast Cancer","enrollment":60},{"nctId":"NCT05639946","phase":"PHASE3","title":"Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2023-01-01","conditions":"Spinal Cord Injuries, Neuropathic Pain","enrollment":44},{"nctId":"NCT05013112","phase":"NA","title":"Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2023-01-01","conditions":"Kidney Transplantation, Metabolic Disorder, Metformin","enrollment":105},{"nctId":"NCT06345443","phase":"NA","title":"NRM on Vascular Perfusion in Healthy Adults","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2024-11-25","conditions":"Vascular Stiffness","enrollment":200},{"nctId":"NCT02064673","phase":"PHASE3","title":"Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy","status":"RECRUITING","sponsor":"yair lotan","startDate":"2014-05","conditions":"Prostate Cancer","enrollment":608},{"nctId":"NCT07214571","phase":"PHASE2","title":"A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease","status":"RECRUITING","sponsor":"Shionogi","startDate":"2025-12-11","conditions":"Respiratory Syncytial Virus Infections","enrollment":192},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":96,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo"],"phase":"marketed","status":"active","brandName":"placebo BID","genericName":"placebo BID","companyName":"Inotek Pharmaceuticals Corporation","companyId":"inotek-pharmaceuticals-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}